HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors.
MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education, and prevention. MD Anderson has ranked among the nation's top ...
ABC13 Houston on MSN17d
New MD Anderson Cancer Center research reveals rise in cervical cancerA report released on Monday by MD Anderson Cancer Center researchers reveals a troubling trend in cervical cancer.After decades of progress, new data shows more women are being diagnosed now than in ...
The University of Texas MD Anderson Cancer Center today announced a $9 million gift from the F. W. Bert and Mae Dean Wheeler Foundation to establish the F. W. Bert and Mae Dean Wheeler Nurse ...
The Cancer Prevention and Research Institute of Texas (CPRIT) awarded the University of Texas MD Anderson Cancer Center nearly $23 million in support of 20 cancer research projects to advance new ...
Hosted on MSN1mon
MD Anderson, Texas Children’s approve pediatric cancer partnershipAccording to the agenda for today’s board meeting, officials from MD Anderson Cancer Center and Texas Children’s Hospital considered a “collaborative relationship in pediatric oncology.” ...
The University of Texas MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education and prevention. MD Anderson provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback